RSV vaccine

Zoom - Invite to be emailed a few days prior to the webinar

APNA will be conducting a webinar on Tuesday, 27 February, from 6:30-7:30pm AEDT.

The first respiratory syncytial virus (RSV) vaccine, AREXVY, has been approved in Australia and will soon be available for older adults to protect them in advance of the 2024 virus season. Following the recent announcement of regulatory approval for the vaccine in Australia, for the purpose of actively immunising individuals aged 60 and above to prevent lower respiratory tract disease caused by RSV.

This webinar aims to assist healthcare providers in ensuring the proper use and safe administration for eligible patients.

The Australian Primary Health Care Nurses Association acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.


© Copyright 2024 Australian Primary Health Care Nurses Association (APNA). All rights reserved. MRM by Bond Software.

Cart

Item removed. Undo